High miR-34a expression improves response to doxorubicin in diffuse large B-cell lymphomaSara Correia Marques, Karen Dybkær, Laura Krogh Jørgensen et al.|Experimental Hematology|2016Cited by 68
High CXCR4 expression impairs rituximab response and the prognosis of R-CHOP-treated diffuse large B-cell lymphoma patientsMaria Bach Laursen, Karen Dybkær, Linn Reinholdt et al.|Oncotarget|2019Cited by 28
Epidemiology and characteristics of validated mixed phenotype acute leukaemia—A comprehensive nationwide Danish cohort studyLisa‐Maj Christensen, Marianne Tang Severinsen, Daniel Tuyet Kristensen et al.|British Journal of Haematology|2025Cited by 1